Drawing for ADAMONITOR

USPTO serial 79380984

ADAMONITOR

Reviewed by CopyMark Law Group

Reg. 7404348Status 404
Filing date
Status date
Registration date
Jun 4, 2024
Examiner
WOLFSEN, CHRISTIANNE LISBETH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADAMONITOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori B. Cohen

Lori B. Cohen Womble Bond Dickinson950 THIRD AVENUENew York, NY 10022

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus, namely, hemoperfusion apparatus for removing blood cells by extracorporeal circulation; medical apparatus and instruments, namely, blood circulating pumpsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 2, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jul 2, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 29, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 11, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 11, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 14, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 20, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 20, 2024FIMPFINAL DISPOSITION PROCESSED—
Sep 4, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 4, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 4, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 28, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 12, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2023RFNTREFUSAL PROCESSED BY IB—
Nov 7, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 7, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 7, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2023DOCKASSIGNED TO EXAMINER—
Oct 20, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 16, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 12, 2023SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance